Chinese english Germany Japanese Korea

229614-17-9

229614-17-9 Struktur
229614-17-9
CAS-Nr.
229614-17-9
Englisch Name:
229614-17-9
Synonyma:
Paramivir impurity 23;Peramivir impurities1;Peramivir impurities435;Peramivir Impurity 49 HCl;methyl (1S,2S,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-amino-2- hydroxycyclopentane-1-carboxylate hydrochloride
CBNumber:
CB45424119
Summenformel:
C15H29ClN2O4
Molgewicht:
336.86
MOL-Datei:
229614-17-9.mol
Request For Quotation

229614-17-9 Eigenschaften

Sicherheit

229614-17-9 Chemische Eigenschaften,Einsatz,Produktion Methoden

229614-17-9 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

229614-17-9 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 10)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Scinova Biotech(Guangzhou) Co., Ltd. 13268215580
 scinova_sales@163.com China 7026 58
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-52878169 15701683040
 sales@bjcomparison.com China 4701 58
Shijiazhuang yaoBo Pharmaceutical Co., Ltd. 15633056635
 2880679888@qq.com China 2740 58
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
 3003392093@qq.com China 7934 55
Heyuan broad spectrum Biotechnology Co., Ltd 0762-3393039 18023108599
 2853058244@qq.com China 982 58
Hunan Zengda Biological Technology Co., LTD 18711085600
 1652923704@qq.com China 4583 58
Cato Research Chemicals Inc. 020-81960175-877 18933936954
 tianwen.zhan@cato-chem.com China 7722 58
Suzhou Meishi Biotechnology Co., Ltd. 1173954148q
 meishipharma@126.com China 20035 58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 18162595016
 3287908757@qq.com China 9887 58
Shenzhen Qingtian Biotechnology Co, Ltd. 18823167005 18162969855
 744288988@qq.com China 2628 58
  • methyl (1S,2S,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-amino-2- hydroxycyclopentane-1-carboxylate hydrochloride
  • Peramivir impurities435
  • Peramivir impurities1
  • Paramivir impurity 23
  • Peramivir Impurity 49 HCl
  • 229614-17-9
Copyright 2019 © ChemicalBook. All rights reserved